Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| PRLD (Prelude Therapeutics Incorporated) | 26.21% | 289.36% | -14.91% | -34.79% | NA | NA | NA | … | … |
Data as of 06/03/2026, Common starting date is 09/28/2020
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| PRLD (Prelude Therapeutics Incorporated) | 09/28/2020 | 06/03/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | -12.02 | 289.36 | -14.91 | -34.79 | NA | NA | NA | … | … | 26.21 | 92.91 | -68.62 | -29.30 | -51.49 | -82.60 | 157.47 |
| Sharpe Ratio | NA | 1.97 | -0.11 | -0.32 | NA | NA | NA | … | … | 0.85 | 0.56 | -0.61 | -0.40 | -0.63 | -0.89 | 33.74 |
| Standard Deviation(%) | NA | 169.09 | 131.86 | 116.67 | NA | NA | NA | … | … | 124.86 | 163.29 | 123.80 | 85.27 | 84.18 | 92.39 | 106.70 |
| Draw Down(%) | NA | 70.10 | 90.42 | 98.42 | NA | NA | NA | … | … | 37.59 | 70.10 | 87.44 | 79.19 | 69.74 | 87.03 | 36.23 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/03/2026, Common starting date is 09/28/2020
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| PRLD (Prelude Therapeutics Incorporated) |
-63.67%
Oct 2020 – Oct 2023 |
-50.92%
Jan 2021 – Jan 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| PRLD (Prelude Therapeutics Incorporated) |
-6.80%
Apr 2023 – Apr 2026 |
-33.90%
Apr 2021 – Apr 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart